Carprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H12ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FFL0D546HO, chemically known as 9h-carbazole-2-acetic acid, 6-chloro-alpha-methyl- but generally known as carprofen, which bears US NIH Compound Identifier 2581. European Medicines Agency schedules Carprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06144MIG. The term CARPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). CARPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carprofen under HS 29339990 and SITC 51577. As of Q4 2014, CARPROFEN remains the US FDA Preferred Term for this commodity. Carprofen bears US NLM identifiers UMLS ID C0054827 and NCI Concept Code C65290. SMILES: CLC1CC2C3C([NH]C2CC1)CC(C(C)C(=O)O)CC3.